reference/13337239

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/13337239

Outgoing Links

Predicate	Object
contentType	Comparative Study\|Journal Article
endingPage	22
issn	0019-509X
issueIdentifier	4
pageRange	318-22
publicationName	Indian Journal of Cancer
startingPage	318
bibliographicCitation	Prabhash K, Medhekar A, Biswas S, Kurkure P, Nair R, Kelkar R. Comparison of in vitro activities of ceftazidime, piperacillin-tazobactam, and cefoperazone-sulbactam, and the implication on empirical therapy in patients with cancer. Indian J Cancer. 2009 Oct;46(4):318–22. doi: 10.4103/0019-509x.55552. PMID: 19749462.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a92ee0f0a87c8dacd279d9d191c64cbd http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_810a3b538cdfb6369c977c2d163e9449 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_50fe1fefddaf2ad87d841f87a9c2261f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_285535f46de8dfafc65e29afcf2c2fd3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7621642a856a33b7ea2e255743d7fbb9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_544fa159bc11e943d7ec67dd694e3b18
date	200910
identifier	https://pubmed.ncbi.nlm.nih.gov/19749462 https://doi.org/10.4103/0019-509x.55552
isPartOf	https://portal.issn.org/resource/ISSN/0019-509X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4195
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Comparison of in vitro activities of ceftazidime, piperacillin-tazobactam, and cefoperazone-sulbactam, and the implication on empirical therapy in patients with cancer
discusses	http://id.nlm.nih.gov/mesh/M0016125 http://id.nlm.nih.gov/mesh/M0016883 http://id.nlm.nih.gov/mesh/M0020733 http://id.nlm.nih.gov/mesh/M0003720 http://id.nlm.nih.gov/mesh/M0226081 http://id.nlm.nih.gov/mesh/M0448397 http://id.nlm.nih.gov/mesh/M0003729
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D002438Q000494 http://id.nlm.nih.gov/mesh/D009369Q000188 http://id.nlm.nih.gov/mesh/D002442Q000494 http://id.nlm.nih.gov/mesh/D000900Q000494 http://id.nlm.nih.gov/mesh/D013407Q000494
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D001424Q000188 http://id.nlm.nih.gov/mesh/D001424Q000209 http://id.nlm.nih.gov/mesh/D006090Q000187 http://id.nlm.nih.gov/mesh/D000077725 http://id.nlm.nih.gov/mesh/D012189 http://id.nlm.nih.gov/mesh/D010397Q000031 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D004352 http://id.nlm.nih.gov/mesh/D009369Q000150 http://id.nlm.nih.gov/mesh/D010397Q000494 http://id.nlm.nih.gov/mesh/D010878Q000494 http://id.nlm.nih.gov/mesh/D008826 http://id.nlm.nih.gov/mesh/D036262
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID130313 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45114137 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID121225277 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID43672 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44298077 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23724843 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66509024 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8167 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91713 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2650 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663400 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7317 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5484131 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID133687818 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5481173 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7062 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44187

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129105226 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128850235 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127859141 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID136079594 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135951164

Total number of triples: 71.